MPO and anti-neutrophil cytoplasmic antibody-associated vasculitis: Approximately 15 years after his initial EGPA diagnosis - and prior to receiving any immunotherapy - he developed progressive lower limb weakness and sensory symptoms, prompting the current admission and revealing a relapse of myeloperoxidase (MPO)-positive ANCA-associated vasculitis.